Copper peptides, known scientifically as GHK-Copper or GHK-Cu, have captured the attention of social media skincare enthusiasts. Users apply an electric-blue solution on their skin or use syringes for administration. This compound is popular for claims of firm, wrinkle-free skin, improved hair, and anti-aging benefits. This trend reflects a broader peptide craze in wellness.
GHK-Cu, while not an approved drug, is supported by substantial scientific research. Topical copper peptide creams have existed for decades, studied in clinical trials. A shift in application methods has occurred recently, with many opting for subcutaneous injections instead of topical use. These injections are often combined with other peptides touted for tissue repair. However, no human studies confirm the safety or effectiveness of such practices. Many obtain injectables from unregulated online markets, raising safety concerns.
Dr. Warren Ladiges: “I think GHK can have a major role in helping enhance longevity…But injecting yourself without really knowing what it’s going to do? I wouldn’t do that to myself.”
The Science Behind Copper Peptides
Copper peptides have a long history, first isolated in the 1970s by chemist Loren Pickart. He found that GHK, a tripeptide, helped rejuvenate liver cells when exposed to young adults’ plasma. Further studies revealed GHK-Cu’s role in promoting collagen production, vascular growth, and anti-inflammatory effects.
Clinical trials primarily show GHK-Cu’s benefits for skin health, such as improved thickness, elasticity, reduced wrinkles, and enhanced hair growth. Dr. David Goldberg highlights its effects on collagen, comparing them to other topical treatments like Vitamin C. Beyond skin, GHK-Cu has shown promise in pre-clinical settings for wound healing and organ repair, including lung fibrosis. Despite its potential, moving this research into human trials has proven challenging.
Regulatory Challenges and Risks
GHK-Cu’s emergence as a ‘beauty peptide’ on social media lets consumers express interest in injections, believing they might provide better results. Dr. David Goldberg advises caution, noting the lack of human studies on injectable safety. Animal studies suggest GHK-Cu is generally safe, yet injections present risks, such as excessive copper absorption and immune reactions.
Dr. Marisa Garshick warns about sourcing injectables from unregulated suppliers, questioning the authenticity of the products. This regulatory uncertainty persists for GHK-Cu and similar peptides, though efforts to reclassify them are ongoing. Compounding pharmacies in the U.S. face restrictions on offering GHK-Cu for human injection, yet changes might occur following FDA advisory panel discussions.
Clinical Observations
Doctor Erik Marks, from a wellness clinic in Seattle, sees numerous patients concerned about self-injected GHK-Cu purchased online. Issues like injection site irritation, infections, and liver complications arise. Marks provides GHK-Cu as a serum, cream, and sometimes injections, sourced from licensed U.S. pharmacies.
Based on his clinical experience, topical applications seem more effective for skin and hair. Injections bring minimal impact. Marks emphasizes that peptides aren’t quick fixes for health issues, encouraging understanding of their limitations.